TokenPost·
Xenetic Biosciences Posts $0.72 GAAP Loss Per Share as Revenue Falls 29.4%
Revenue totaled $0.7 million in the third quarter of 2026.
More news
- crypto.newsRobinhood crypto volume falls 21% as event contracts hit 5.9B
- TokenPostLogansport Financial Sets Its Third-Quarter Dividend at $0.45
- TokenPostBanks Collect $1.6 Billion in Q3 Overdraft Fees, a Four-Year High
- TokenPostStoneX Starts Deckers Coverage With Buy Rating, $110 Target
- Crypto BriefingBitcoin may face one final decline before cycle recovery, Hashdex CIO says
- CoinspeakerBitcoin Demand Dries Up as Miners Prepare to Dump 2,077 BTC: Is More Selling Pressure Coming for BTC?